Ovintiv Inc. Quarterly Operating Income (Loss) in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ovintiv Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q3 2024.
  • Ovintiv Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $527M, a 12.8% increase year-over-year.
  • Ovintiv Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $2.77B, a 2.64% decline year-over-year.
  • Ovintiv Inc. annual Operating Income (Loss) for 2023 was $2.86B, a 25.7% decline from 2022.
  • Ovintiv Inc. annual Operating Income (Loss) for 2022 was $3.85B, a 154% increase from 2021.
  • Ovintiv Inc. annual Operating Income (Loss) for 2021 was $1.52B.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.77B $527M +$60M +12.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.71B $556M +$25M +4.71% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $2.68B $494M -$184M -27.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $2.86B $1.19B +$24M +2.06% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $2.84B $467M -$906M -66% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $3.75B $531M -$985M -65% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $4.73B $678M +$878M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.85B $1.16B -$281M -19.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $4.13B $1.37B +$1.37B Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.76B $1.52B +$1.64B Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $1.12B -$200M -$395M -203% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $1.52B $1.45B +$2.04B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$517M $0 +$1.51B Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$2.02B -$121M +$3.94B +97% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$5.96B $195M -$564M -74.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$5.4B -$591M -$563M -2011% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-18
Q3 2020 -$4.83B -$1.51B -$1.82B -578% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$3.01B -$4.06B -$4.6B -854% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $1.58B $759M +$986M Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-29
Q4 2019 $598M -$28M -$1.38B -102% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-18
Q3 2019 $1.98B $315M +$196M +165% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-18
Q2 2019 $1.78B $538M +$654M Apr 1, 2019 Jun 30, 2019 10-K 2021-02-18
Q1 2019 $1.13B -$227M -$564M -167% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-18
Q4 2018 $1.69B $1.35B Oct 1, 2018 Dec 31, 2018 10-K 2020-02-21
Q3 2018 $119M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-21
Q2 2018 -$116M Apr 1, 2018 Jun 30, 2018 10-K 2020-02-21
Q1 2018 $337M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.